Chirality in metal-based anticancer agents-Reference-Cited by-同舟云学术

Chirality in metal-based anticancer agents

Published:2018 Issue:12 Volume:47 Page:4017-4026
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Wang Yi¹²³⁴⁵^ORCID,Huang Huaiyi⁶⁷⁸⁹^ORCID,Zhang Qianling¹²³⁴⁵^ORCID,Zhang Pingyu¹²³⁴⁵^ORCID

Affiliation:

1. College of Chemistry and Environmental Engineering

2. Shenzhen University

3. Shenzhen

4. 518060

5. P. R. China

6. Department of Chemistry

7. University of Warwick

8. Coventry

9. UK

Abstract

Chiral metal-based drugs are currently an interesting and rapidly growing field in anticancer research. Here the different chiral metal-based anticancer agents and the extent to which the chiral resolution affects their biological properties are discussed. This review will aid the design of new potent and efficient chiral metal-based anticancer drugs that exploit the unique properties combined with their potential selectivity toward targeted chiral biomolecules.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2018/DT/C8DT00089A

Reference94 articles.

1. Thalidomide: The Tragedy of Birth Defects and the Effective Treatment of Disease

2. In vitro and in vivo investigation of dexibuprofen derivatives for CNS delivery

3. Chiral discrimination and enantioselective analysis of drugs: An overview

4. Chiral Amplification by Self‐Assembly of Neutral Luminescent Platinum(II) Complexes

5. An Amphiphilic Ruthenium Polymetallodrug for Combined Photodynamic Therapy and Photochemotherapy In Vivo

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asymmetric synthesis of stereogenic-at-iridium(III) complexes through Pd-catalyzed kinetic resolution;Nature Communications;2025-01-30

2. Chirality in metal-based antimicrobial agents: a growing frontier in biomedical research;Dalton Transactions;2025

3. From extract to chiral analyses of the natural products;Phytochemicals for Health;2025

4. Dinuclear Ru(II) Complexes Containing Tetrapyrido[3,2‐a : 2,3‐c : 3,2‐h : 2′′′,3′′′‐j]Phenazine Ligand for Biomedical Applications;ChemBioChem;2024-12-20

5. A comprehensive review on the development of chiral Cu, Ni, and Zn complexes as pharmaceutical agents over the past decades: Synthesis, molecular structure and biological activity;Medicinal Research Reviews;2024-09-19